Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ICU MedicalICUI -0.05%81 Earnings per Share (Diluted) is $1.18 as of Jun. 2026. GuruFocus rates ICUI with a GF Score™ of 81/100 and a GF Value™ of $120.63 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 656 Medical Devices & Instruments companies, ICU Medical ranks worse than 152438.87% on this metric.
ICU Medical's EPS (Basic) for the
three
months ended in Jun. 2026 was $0.76.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2026 was $1.20.
ICU Medical's EPS without NRI for the
three
months ended in Jun. 2026 was $1.39.
Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2026 was $5.08.
During the past 13 years, ICU Medical's highest 3-Year average EPS without NRI Growth Rate was 62.40% per year. The lowest was -35.50% per year. And the median was 13.50% per year.
ICU Medical (NAS:ICUI) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
ICU Medical Earnings per Share (Diluted) Related Terms
ICU Medical Earnings per Share (Diluted) Historical Data
* Premium members only.
The historical data trend for ICU Medical's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ICUI vs NVST, MMSI, MMED: Earnings per Share (Diluted) Comparison
For the Medical Instruments & Supplies subindustry, ICU Medical's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ICU Medical PE Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ICU Medical's PE Ratio distribution charts can be found below:
* The bar in red indicates where ICU Medical's PE Ratio falls into.
ICU Medical Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
ICU Medical's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2025 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.18
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of $1.18 mean?
ICU Medical (ICUI) has a Earnings per Share (Diluted) of $1.18 as of Jun. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on ICU Medical and its competitors. According to the industry distribution chart, ICU Medical ranks #999999 out of 656 companies in the Medical Devices & Instruments industry.
Is ICU Medical's Earnings per Share (Diluted) too high?
ICU Medical's current Earnings per Share (Diluted) is $1.18. The Medical Devices & Instruments industry median Earnings per Share (Diluted) is 8.05. ICU Medical's value of $1.18 is 85.3% below this industry median. Based on the distribution chart, ICU Medical ranks #999999 out of 656 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, ICU Medical has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does ICU Medical's Earnings per Share (Diluted) compare to NVST and MMSI?
According to the Medical Devices & Instruments industry distribution chart, ICU Medical ranks #999999 out of 656 companies for Earnings per Share (Diluted). This places ICU Medical in the lower half of its industry. The industry median Earnings per Share (Diluted) is 8.05. ICU Medical's value of $1.18 is 85.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Medical Devices & Instruments company?
The median Earnings per Share (Diluted) among Medical Devices & Instruments companies is 8.05, based on 656 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ICU Medical's current Earnings per Share (Diluted) of $1.18 is 85.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on ICU Medical and its competitors. For the Medical Devices & Instruments industry, the median Earnings per Share (Diluted) is 8.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ICU Medical's current Earnings per Share (Diluted) is $1.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ICU Medical stock overvalued right now?
Based on GuruFocus' analysis, ICU Medical (ICUI) is currently considered Significantly Overvalued. The stock's GF Value™ is $120.63, compared to a current price of $182.44 — trading 51.2% above its estimated fair value. The current Earnings per Share (Diluted) is $1.18 and 85.3% below the Medical Devices & Instruments industry median of 8.05. ICU Medical's overall GF Score™ is 81/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For ICU Medical (ICUI), the current Earnings per Share (Diluted) is $1.18 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ICU Medical (ICUI) Overvalued in 2026?
Based on GuruFocus' analysis, ICU Medical stock appears to be overvalued.
The current stock price of $182.44 is trading 51.2% above its estimated GF Value™ of $120.63.
GuruFocus considers ICU Medical to be Significantly Overvalued.
Key valuation signals for ICUI:
Earnings per Share (Diluted): $1.18
GF Value™: $120.63 vs. price of $182.44 (51.2% above fair value)
Industry Position: 85.3% below the Medical Devices & Instruments median (#999999 of 656)
No single metric tells the full story. See the ICUI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.
81GF Score
Get the complete analysis for ICUI
Earnings per Share (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ICUI has been successfully added to your 
